tiprankstipranks
Krystal Biotech (KRYS)
NASDAQ:KRYS
US Market

Krystal Biotech (KRYS) Income Statement

Compare
461 Followers

Krystal Biotech Income Statement

Last quarter (Q2 2024), Krystal Biotech's total revenue was $83.84M, an increase of 879.91% from the same quarter last year. In Q2, Krystal Biotech's net income was $27.18M. See Krystal Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 50.70M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 47.60M$ -4.05M$ -2.77M$ -1.85M$ -974.00K
Operating Expenses
$ 157.33M$ 120.20M$ 68.28M$ 33.00M$ 22.08M
Depreciation and Amortization
$ 5.01M$ 4.05M$ 2.77M$ 1.85M$ 974.00K
EBITDA
$ 17.90M$ -145.20M$ -65.31M$ -30.32M$ -18.11M
Operating Income
$ -109.73M$ -145.20M$ -68.28M$ -33.00M$ -22.08M
Other Income/Expenses
$ 122.62M$ 5.22M$ -1.29M$ 832.00K$ 2.99M
Pretax Income
$ 12.90M$ -139.97M$ -69.57M$ -32.17M$ -19.09M
Net Income
$ 10.93M$ -139.97M$ -69.57M$ -32.17M$ -19.09M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.40$ -5.49$ -3.13$ -1.71$ -1.20
Diluted EPS
$ 0.39$ -5.49$ -3.13$ -1.71$ -1.20
Weighted Average Shares Outstanding
27.15M 25.49M 22.20M 18.79M 15.90M
Weighted Average Shares Outstanding (Diluted)
27.75M 25.49M 22.20M 18.79M 15.90M
Currency in USD

Krystal Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis